易瑞生物 (300942.SZ)

今开: 最高: 成交量:

昨收: 最低: 成交额:

+ 收藏

利润表(易瑞生物)

导出到EXCEL
报表日期选择
  • 常用日期查询
  • 自定义年度查询
    日期范围
    报告期
    报告类型
    显示选项
关 闭
完整财报对比
2023年三季报2023年中报2023年一季报2022年年报2022年三季报2022年中报2022年一季报
上市前/上市后 上市后上市后上市后上市后上市后上市后上市后
报表类型 合并报表合并报表合并报表合并报表合并报表合并报表合并报表
一、营业总收入(元) 165,099,285.79112,111,327.4960,707,585.25686,897,476.53572,094,603.75474,669,027.13294,001,215.63
 营业收入(元) 165,099,285.79112,111,327.4960,707,585.25686,897,476.53572,094,603.75474,669,027.13294,001,215.63
二、营业总成本(元) 244,638,062.81184,963,695.4894,325,423.68555,470,050.87410,324,638.63295,820,536.13155,220,845.49
 营业成本(元) 84,644,515.3968,030,792.1145,522,665.69298,761,963.04219,867,493.98168,126,597.6796,408,256.89
 研发费用(元) 48,609,330.9840,507,628.3818,391,842.45111,417,764.5260,545,237.8140,725,433.5715,605,979.98
 营业税金及附加(元) 3,305,422.74846,888.92480,006.772,597,083.522,196,382.772,080,199.571,191,075.42
 销售费用(元) 53,006,160.1039,355,577.8216,621,519.5458,904,605.6954,615,202.6137,971,336.6218,520,216.53
 管理费用(元) 61,540,272.3544,505,813.3013,980,882.2492,285,424.2886,350,264.9755,359,983.9923,386,279.42
 财务费用(元) -6,467,638.75-8,283,005.05-671,493.01-8,496,790.18-13,249,943.51-8,443,015.29109,037.25
  其中:利息费用(元) 4,498,644.383,537,278.301,180,065.094,083,484.101,675,608.00955,256.53496,427.02
  其中:利息收入(元) 6,010,499.293,957,325.09-2,244,905.533,564,414.392,763,808.352,245,252.44271,715.23
三、其他经营收益
 加:公允价值变动收益(元) 152,070.07152,070.0799,750.00--3,669,365.84-3,666,729.561,900,000.00
 加:投资收益(元) -7,949,168.23-5,134,534.80-3,718,625.022,676,204.897,731,677.506,873,850.251,070,843.57
  其中:对联营企业和合营企业的投资收益(元) -8,520,380.56-5,494,863.57-3,718,625.02-3,855,810.55-1,045,676.54-623,277.16-282,979.41
 资产处置收益(元) 2,588,935.562,134,806.6220,525.581,430,664.45241,797.14109,521.71-
 资产减值损失(元) -17,030,774.29-12,645,004.05--48,337,002.47-1,459,853.38-964,439.83-
 信用减值损失(元) -2,526,588.32-358,709.221,611,479.50-3,863,461.80-392,692.62-1,888,257.62-6,078,087.17
 其他收益(元) 9,217,965.424,910,767.052,070,494.5514,773,586.8111,814,809.605,264,933.503,607,191.32
四、营业利润(元) -95,086,336.81-83,792,972.32-33,534,213.8298,107,417.54176,036,337.52184,577,369.45139,280,317.86
 加:营业外收入(元) 872,079.40757,656.5593,239.42170,608.3144,124.1644,124.1627,963.06
 减:营业外支出(元) 2,024,544.84959,742.842,411.993,391,847.644,332.661,024.34161.11
五、利润总额(元) -96,238,802.25-83,995,058.61-33,443,386.3994,886,178.21176,076,129.02184,620,469.27139,308,119.81
 减:所得税费用(元) 2,977,809.62-14,319,168.36-5,357,991.5512,222,382.8427,784,177.9533,260,904.3925,209,821.95
六、净利润(元) -99,216,611.87-69,675,890.25-28,085,394.8482,663,795.37148,291,951.07151,359,564.88114,098,297.86
(一)按经营持续性分类
  持续经营净利润(元) -99,216,611.87-69,675,890.25-28,085,394.8482,663,795.37148,291,951.07151,359,564.88114,098,297.86
(二)按所有权归属分类
  归属于母公司股东的净利润(元) -99,158,554.33-69,632,293.13-28,061,115.0382,965,490.95148,364,765.08151,413,759.86114,128,972.49
  少数股东损益(元) -58,057.54-43,597.12-24,279.81-301,695.58-72,814.01-54,194.98-30,674.63
 扣除非经常性损益后的净利润(元) -108,344,442.96-75,578,516.96-29,816,754.2665,469,565.40133,769,011.73143,556,039.38108,295,508.03
七、每股收益
 一、基本每股收益(元) -0.25-0.17-0.070.210.370.380.28
 二、稀释每股收益(元) -0.25-0.17-0.070.210.370.380.28
八、其他综合收益(元) 1,803,253.062,622,166.4443,114.26189,564.331,267,445.97165,429.74-80,411.67
 归属于母公司股东的其他综合收益(元) 1,803,253.062,622,166.4443,114.26189,564.331,267,445.97165,429.74-80,411.67
九、综合收益总额(元) -97,413,358.81-67,053,723.81-28,042,280.5882,853,359.70149,559,397.04151,524,994.62114,017,886.19
 归属于母公司所有者的综合收益总额(元) -97,355,301.27-67,010,126.69-28,018,000.7783,155,055.28149,632,211.05151,579,189.60114,048,560.82
 归属于少数股东的综合收益总额(元) -58,057.54-43,597.12-24,279.81-301,695.58-72,814.01-54,194.98-30,674.63
公告日期 2023-10-272023-08-302023-04-262023-04-262022-10-282022-08-302022-04-27
审计意见(境内) 标准无保留意见
原始财报文件下载 下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)下载财报(PDF)

前瞻产业研究院